| P50 | author | Thomas M Stulnig | Q44539480 |
| | Josef S Smolen | Q66753681 |
| P2093 | author name string | Oskar Hoffmann | |
| | Reinhold G Erben | |
| | Matthias Mack | |
| | Thomas Pap | |
| | Nikolaus B Binder | |
| | Birgit Niederreiter | |
| | Kurt Redlich | |
| | Richard Stange | |
| P2860 | cites work | Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails | Q24310185 |
| | Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation | Q24311588 |
| | RANK is essential for osteoclast and lymph node development | Q24598872 |
| | Bone resorption by osteoclasts | Q28145169 |
| | CCL9/MIP-1gamma and its receptor CCR1 are the major chemokine ligand/receptor species expressed by osteoclasts | Q28210471 |
| | MCP-1 is induced by receptor activator of nuclear factor-{kappa}B ligand, promotes human osteoclast fusion, and rescues granulocyte macrophage colony-stimulating factor suppression of osteoclast formation | Q28236005 |
| | Denosumab in postmenopausal women with low bone mineral density | Q28298728 |
| | SHIP-deficient mice are severely osteoporotic due to increased numbers of hyper-resorptive osteoclasts | Q28510858 |
| | Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice | Q28585385 |
| | OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis | Q28589430 |
| | Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee | Q29616160 |
| | A rapid single-laser flow cytometric method for discrimination of early apoptotic cells in a heterogenous cell population. | Q30656299 |
| | Osteopetrosis | Q34380528 |
| | Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors | Q34520133 |
| | Estrogen deficiency and bone loss: an inflammatory tale | Q34576622 |
| | Repair of local bone erosions and reversal of systemic bone loss upon therapy with anti-tumor necrosis factor in combination with osteoprotegerin or parathyroid hormone in tumor necrosis factor-mediated arthritis | Q35083436 |
| | Differentiation and function of osteoclasts | Q35113943 |
| | Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites | Q35664094 |
| | Mechanisms of action of antiresorptive therapies of postmenopausal osteoporosis. | Q35755088 |
| | CD44 is a determinant of inflammatory bone loss | Q36403383 |
| | Direct and indirect estrogen actions on osteoblasts and osteoclasts | Q36532519 |
| | Additive roles for MCP-1 and MCP-3 in CCR2-mediated recruitment of inflammatory monocytes during Listeria monocytogenes infection. | Q36661058 |
| | Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha | Q37271202 |
| | Identification and characterization of the new osteoclast progenitor with macrophage phenotypes being able to differentiate into mature osteoclasts | Q40862968 |
| | IL-1 mediates TNF-induced osteoclastogenesis | Q40909592 |
| | Role of cytokines in bone resorption | Q40957399 |
| | Effect of hormone replacement therapy on nitric oxide bioactivity and monocyte chemoattractant protein-1 levels | Q43787126 |
| | Monocyte chemoattractant protein-1 induces proliferation and interleukin-6 production in human smooth muscle cells by differential activation of nuclear factor-kappaB and activator protein-1. | Q44030294 |
| | Estrogen decreases expression of chemokine receptors, and suppresses chemokine bioactivity in murine monocytes | Q44729731 |
| | Systemic tumor necrosis factor alpha mediates an increase in peripheral CD11bhigh osteoclast precursors in tumor necrosis factor alpha-transgenic mice | Q44733643 |
| | Association of a polymorphism of the CC chemokine receptor-2 gene with bone mineral density | Q45887159 |
| | Induction of chemokines and chemokine receptors CCR2b and CCR4 in authentic human osteoclasts differentiated with RANKL and osteoclast like cells differentiated by MCP-1 and RANTES. | Q46741114 |
| | The expression of CCL2 by T lymphocytes of mammary tumor bearers: role of tumor-derived factors | Q46769001 |
| | Cytokines, hematopoiesis, osteoclastogenesis, and estrogens | Q68182334 |
| | Tamoxifen inhibits osteoclast-mediated resorption of trabecular bone in ovarian hormone-deficient rats | Q68267253 |
| | Evaluation of serum osteocalcin as an index of altered bone metabolism | Q70144072 |
| | Biochemical markers of bone turnover in Paget's disease | Q72780083 |
| | Macrophage inflammatory protein 1-alpha is a potential osteoclast stimulatory factor in multiple myeloma | Q73971509 |
| | Sex steroids and bone | Q74124341 |
| | Chemokine receptors | Q74481121 |
| | Regulation of monocyte chemotactic protein-1 expression in human endometrial stromal cells by estrogen and progesterone | Q77905995 |
| | Targeting MEK1/2 blocks osteoclast differentiation, function and cytokine secretion in multiple myeloma | Q81248007 |
| | MCP-1-induced human osteoclast-like cells are tartrate-resistant acid phosphatase, NFATc1, and calcitonin receptor-positive but require receptor activator of NFkappaB ligand for bone resorption | Q81464707 |
| | Expression and characterization of the chemokine receptors CCR2 and CCR5 in mice | Q95721029 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | osteoporosis | Q165328 |
| P304 | page(s) | 417-424 | |
| P577 | publication date | 2009-03-29 | |
| P1433 | published in | Nature Medicine | Q1633234 |
| P1476 | title | Estrogen-dependent and C-C chemokine receptor-2-dependent pathways determine osteoclast behavior in osteoporosis. | |
| P478 | volume | 15 | |